In the next place, compared GC patients with high versus low expression and production of IL‐17A, the survival rates of 30 months were significantly lower for those GC patients with the higher level of IL‐17A expression and production (Figure 8A and B). The gene discussed is IL17A; the disease is gastric cancer.